Sub-chronic toxicity evaluation of ethyl acetate fraction of fruit rind of “asam kandis†(Garcinia cowa Roxb.) against liver and kidney function of female white mice
Article Sidebar
Main Article Content
Abstract
The sub-chronic toxicity testing of ethyl acetate fraction of fruit rind of “asam kandis†(Garcinia cowa Roxb.) to the liver and kidney function has been carried out to female white mice. A total of 18 female white mice aged 2-3 months weighing 20-30 grams are used as test animals. Animals were divided into three groups: one control group and two treatment groups. Groups were given daily ethyl acetate fraction at the doses of 500 and 1000 mg/kg orally for 60 days. Parameters observed were the activity of SGPT and liver weight ratio to observe the liver function; serum creatinine level and kidney weight ratio to determine kidney function. Data of SGPT, serum creatinine and the weight ratio of liver and kidney were analyzed by two-way ANOVA. Results show that the activity of SGPT and serum creatinine level were directly affected by the dose (p<0.05), while the organ weight ratio of liver and kidney were not affected by the dose and duration of administration (p>0.05). The study concluded that the dosage of ethyl acetate fraction of the fruit rind of G. cowa had a significant effect on the activity of SGPT and serum creatinine level of female white mice. The duration of administration did not give a significant effect on the increase of serum creatine level as well as the organ weight ratio of liver and kidney of mice.
Article Details
The authors retain the copyright and grant the journal the right of first publication simultaneously under the Creative Commons Attribution License. This license allows others to share the work with proper acknowledgment of authorship and initial publication in this journal. Authors are permitted and encouraged to deposit their articles in institutional repositories, on their personal websites, or in other online repositories after the article has been published in JSFK.
References
Perhimpunan Dokter Paru Indonesia. (2003). Pneumonia Komuniti: Pedoman Diagnosa dan Penatalaksanaan di Indonesia, Perhimpunan Dokter Paru Indonesia.
Departemen Kesehatan Republik Indonesia. (2013). Profil Kesehatan Indonesia 2013. Jakarta: Departemen Kesehatan.
World Health Organization (WHO). Rational Use of Medicines. 2012 . Diakses dari https://www.who.int/medicines/areas/rational_use/en/
Departemen Kesehatan Republik Indonesia. (2012). Profil Kesehatan Indonesia 2011. Jakarta: Departemen Kesehatan.
Dinas Kesehatan Provinsi Sumatera Barat. (2013). Profil Kesehatan Provinsi Sumatera Barat Tahun 2012. Padang: Dinas Kesehatan.
Departemen Kesehatan RI, Direktorat Bina Farmasi Komunitas dan Klinis. (2005). Pharmaceutical Care Untuk Penyakit Infeksi Saluran Pernapasan. Jakarta.
Bahry, B. (1989). Kesenjangan Peresepan Pada Anak. Prosiding: Kongres Nasional VII Ikatan Farmakologi Indonesia, Yogyakarta Oktober 1989, Fakultas Kedokteran Universitas Andalas Padang.
Jukemura, E. M., Burattini, M. N., Pereira, C. A., Braga, A. L., & Medeiros, E. A. (2007). Control of multi-resistant bacteria and ventilator-associated pneumonia: is it possible with changes in antibiotics?. Brazilian Journal of Infectious Diseases, 11(4), 418-422.
Huang, K. T., Tseng, C. C., Fang, W. F., & Lin, M. C. (2010). An early predictor of the outcome of patients with ventilator-associated pneumonia. Chang Gung Med J, 33(3), 274-282.
Departemen Kesehatan RI. (2009). Pelayanan Kesehatan Anak di Rumah Sakit, Pedoman Bagi Rumah Sakit Rujukan Tingkat Pertama di Kabupaten/Kota, Jakarta.
Suharjono, Y.T, Sumarno, Semedi J. (2009). Studi penggunaan antibiotika pada penderita rawat inap pneumonia (penelitian di sub Departemen Anak Rumkital Dr. Ramelan Surabaya). Majalah Ilmu Kefarmasian, 6(3), 142-155.
Advisedly, A.T., Berawi, M.M. (2014). Antibiotic Utilization Of Pneumonia In Children of 0-59 Month’s Old in Puskesmas Kemiling Bandar Lampung Period Januari-October 2013 (Skripsi). Lampung; Faculty of Medicine Lampung University.
Kementrian Kesehatan Republik Indonesia. (2011). Pedoman Umum Penggunaan Antibiotika. Jakarta: Kementrian Kesehatan.
Darmansjah, I. (2008). Penggunaan Antibiotika pada Pasien Anak. Majalah Kedokteran Indonesia, 58(10).
Priyanto. (2009). Farmakoterapi dan Terminologi Medis. Lembaga Studi dan Konsultasi Farmakologi, Jawa Barat.
Jawetz, E. (1984). Mikrobiologi Untuk Profesi Kesehatan, Edisi 16. Jakarta: Penerbit Buku Kedokteran EGC.
Anonim. (2010). Efek Samping Obat. Yogyakarta: Farmakologi Klinik Fakultas Kedokteran Universitas Gadjah Mada.
Worokarti. (2005). Peran Farmasis Dalam Pengelolaan Penderita Penyakit Infeksi Untuk Mencegah Timbulnya Resistensi Antimikroba. In: Naskah Lengkap Simposium Penyakit Infeksi dan Problema Resistensi Antimikroba. Surabaya: AMRIN Study Group and Infectious Disease Center dan FKUA RSU Dr. Soetomo. hal.55-69.
Ostapchuk, M., Donna, M.R., Richard, H.M.D., (2004). Community-Acquired Pneumoni in Infant and Children, Journal of The American Academy of Family Physicians.
Nugroho, F., Pri I.U., Ika Y. (2011). Evaluasi Penggunaan Antibiotika Pada Penyakit Pneumonia Di Rumah Sakit Umum Daerah Purbalingga (Skripsi). Purwokerto: Universitas Muhammadiyah Purwokerto.
Kaparang, P.C., Tjitrosantoso, H., & Yamlean, P.V.Y. (2014). Evaluasi Kerasionalan Penggunaan Antibiotika Pada Pengobatan Pneumonia Anak Di Instalasi Rawat Inap RSUP Prof. DR. R. Kandou Manado Periode Januari-Desember 2013. Pharmacon Jurnal Ilmiah Farmasi, 3(3), 247-254.
Shargel. (1988). Biofarmasetika dan Farmakokinetik Terapan, Edisi. 2, Penterjemah Fasich dan Siti Syamsiah. Surabaya: Penerbit Universitas Airlangga.
Dipiro, J.T., Robert, L.T., Gary, C.Y., R.M., Barbara, G.W., Michael Posey. (2011). Pharmacotheraphy; A Pathophysiology approach, Eight Ed. Mc GrawHill Companies.